Search Results - Marco Vignetti

Refine Results
  1. 1
    Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia

    Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia by Giovanna Meloni, Robin Foà, Marco Vignetti, Anna Guarini, S. Fenu, S. Tosti, AG Tos, F Mandelli

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival

    Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival by Sabina Chiaretti, Xiaochun Li, Robert Gentleman, Antonella Vitale, Marco Vignetti, Franco Mandelli, Jerome Ritz, Robin Foà

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Autologous Bone Marrow Transplantation for Acute Promyelocytic Leukemia in Second Remission: Prognostic Relevance of Pretransplant Minimal Residual Disease Assessment by Reverse-Transcription Polymerase Chain Reaction of the PML/RARα Fusion Gene

    Autologous Bone Marrow Transplantation for Acute Promyelocytic Leukemia in Second Remission: Prognostic Relevance of Pretransplant Minimal Residual Disease Assessment by Reverse-Tr... by Giovanna Meloni, Daniela Diverio, Marco Vignetti, Giuseppe Avvisati, Saveria Capria, Maria Concetta Petti, Franco Mandelli, Francesco Lo‐Coco

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia

    Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia by Fabio Efficace, Gianantonio Rosti, Neil K. Aaronson, Francesco Cottone, Emanuele Angelucci, Stefano Molica, Marco Vignetti, Franco Mandelli, Michele Baccarani

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis

    Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis by Fabio Efficace, Gary S. Collins, Francesco Cottone, Johannes M. Giesinger, Kathrin Sommer, Amélie Anota, Michael Maia Schlüssel, Paola Fazi, Marco Vignetti

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features

    AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features by Claudia Haferlach, Cristina Mecucci, Susanne Schnittger, Alexander Kohlmann, Marco Mancini, Antonio Cuneo, Nicoletta Testoni, Giovanna Rege‐Cambrin, Antonella Santucci, Marco Vignetti, Paola Fazi, Maria Paola Martelli, Torsten Haferlach, Brunangelo Falini

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study

    Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study by Fabio Efficace, Michele Baccarani, Gianantonio Rosti, Francesco Cottone, Fausto Castagnetti, Massimo Breccia, Giuliana Alimena, Alessandra Iurlo, Alessandro Rossi, Susanna Pardini, Filíppo Gherlinzoni, Marzia Salvucci, Mario Tiribelli, Marco Vignetti, Franco Mandelli

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Randomized trial of two schedules of low‐dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML‐19)

    Randomized trial of two schedules of low‐dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates... by Sergio Amadori, Stefan Suciu, Dominik Selleslag, Roberto Stasi, Giuliana Alimena, Liliana Baila, Vittorio Rizzoli, Erika Borlenghi, Gianluca Gaïdano, Domenico Magro, Giuseppe Torelli, Petra Muus, Adriano Venditti, Emma Cacciola, Francesco Lauria, Marco Vignetti, Théo de Witte

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

    Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional... by Marco Vignetti, Paola Fazi, G. Cimino, Giovanni Martinelli, Francesco Di Raimondo, Felicetto Ferrara, Giovanna Meloni, Achille Ambrosetti, Giovanni Quarta, Livio Pagano, Giovanna Rege‐Cambrin, Loredana Elia, Raffaello Bertieri, Luciana Annino, Robin Foà, Michele Baccarani, Franco Mandelli

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial

    Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial by Sabina Chiaretti, Renato Bassan, Antonella Vitale, Loredana Elia, Alfonso Piciocchi, Cristina Puzzolo, Martina Canichella, Felicetto Ferrara, Monia Lunghi, Francesco Fabbiano, Massimiliano Bonifacio, Nicola Stefano Fracchiolla, Prassede Salutari, Alessandra Mancino, Marco Vignetti, Anna Guarini, Alessandro Rambaldi, Robin Foà

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis

    Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis by Simona Soverini, Alessandro Vitale, Antonio Poerio, Alessandra Gnani, Sabrina Colarossi, Ilaria Iacobucci, G. Cimino, L Elia, Annalisa Lonetti, Marco Vignetti, Stefania Paolini, Giovanna Meloni, V. di Maio, Cristina Papayannidis, Marilina Amabile, Anna Guarini, Michele Baccarani, Giovanni Martinelli, R. Foà

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    P353: FORTY MONTHS UPDATE OF THE GIMEMA LAL2116 (D-ALBA) PROTOCOL AND ANCILLARY LAL2217 STUDY FOR NEWLY DIAGNOSED ADULT PH+ ALL

    P353: FORTY MONTHS UPDATE OF THE GIMEMA LAL2116 (D-ALBA) PROTOCOL AND ANCILLARY LAL2217 STUDY FOR NEWLY DIAGNOSED ADULT PH+ ALL by Sabina Chiaretti, Renato Bassan, A Vitale, L Elia, Alfonso Piciocchi, Piera Viero, Felicetto Ferrara, M. Lunghi, Francesco Fabbiano, Massimiliano Bonifacio, Nicola Stefano Fracchiolla, Paolo Di Bartolomeo, Paola Fazi, M. S. De Propris, Marco Vignetti, Anna Guarini, Alessandro Rambaldi, Robin Foà

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)

    Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1) by Brunangelo Falini, Katja Macijewski, Tamara Weiss, Ulrike Bacher, Susanne Schnittger, Wolfgang Kern, Alexander Kohlmann, Hans‐Ulrich Klein, Marco Vignetti, Alfonso Piciocchi, Paola Fazi, Maria Paola Martelli, Antonella Vitale, Stefano Pileri, Miriam Miesner, Antonella Santucci, Claudia Haferlach, Franco Mandelli, Torsten Haferlach

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party

    The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working... by Ilaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, Cristina Papayannidis, Anna Ferrari, Clelia Tiziana Storlazzi, Marco Vignetti, Daniela Cilloni, F. Messa, Viviana Guadagnuolo, Stefania Paolini, L Elia, Monica Messina, Albert T. Vitale, Giovanna Meloni, Simona Soverini, Fabrizio Pane, Michele Baccarani, Robin Foà, Giovanni Martinelli

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    <i>IKZF1</i>(Ikaros) Deletions in<i>BCR-ABL1</i>–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

    <i>IKZF1</i>(Ikaros) Deletions in<i>BCR-ABL1</i>–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Rela... by Giovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, Marco Vignetti, Francesca Paoloni, Daniela Cilloni, Simona Soverini, Antonella Vitale, Sabina Chiaretti, G. Cimino, Cristina Papayannidis, Stefania Paolini, Loredana Elia, Paola Fazi, Giovanna Meloni, Sergio Amadori, Giuseppe Saglio, Fabrizio Pane, Michele Baccarani, Robin Foà

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study

    A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study by Sabina Chiaretti, Alessandro Vitale, Marco Vignetti, Alfonso Piciocchi, Paola Fazi, L Elia, Brunangelo Falini, Francesca Ronco, Francesca Ferrara, Paolo de Fabritiis, Mario Luppi, Giorgio La Nasa, Andrea Tedeschi, C. Califano, R. Fanin, Sylvain Doré, Franco Mandelli, Giovanna Meloni, R. Foà

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

    Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia by Anna Lucia Fedullo, Monica Messina, Loredana Elia, Alfonso Piciocchi, Valentina Gianfelici, Alessia Lauretti, Stefano Soddu, Maria Cristina Puzzolo, Clara Minotti, Felicetto Ferrara, Bruno Martino, Patrizia Chiusolo, Valeria Calafiore, Stefania Paolini, Marco Vignetti, Antonella Vitale, Anna Guarini, Robin Foà, Sabina Chiaretti

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Temsirolimus, an mTOR inhibitor, in combination with lower‐dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML‐1107)

    Temsirolimus, an mTOR inhibitor, in combination with lower‐dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (... by Sergio Amadori, Roberto Stasi, Alberto M. Martelli, Adriano Venditti, Giovanna Meloni, Fabrizio Pane, Giovanni Martinelli, Monia Lunghi, Livio Pagano, Daniela Cilloni, Elena Rossetti, Francesco Di Raimondo, Claudio Fozza, Luciana Annino, Francesca Chiarini, Francesca Ricci, Emanuele Ammatuna, Edoardo La Sala, Paola Fazi, Marco Vignetti

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

    Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final result... by Sergio Amadori, Stefan Suciu, U. Jehn, Roberto Stasi, Xavier Thomas, Jean‐Pierre Marie, Petra Muus, François Lefrère, Zwi Berneman, Georges Fillet, Claudio Denzlinger, Roel Willemze, Pietro Leoni, Giuseppe Leone, Marco Casini, Francesco Ricciuti, Marco Vignetti, F Beeldens, F Mandelli, Théo de Witte

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life Outcomes

    Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life... by Fabio Efficace, Franco Mandelli, Giuseppe Avvisati, Francesco Cottone, Felicetto Ferrara, Eros Di Bona, Giorgina Specchia, Massimo Breccia, Alessandro Levis, Simona Sica, Olimpia Finizio, Maria Grazia Kropp, Giuseppe Fioritoni, Elisa Cerqui, Marco Vignetti, Sergio Amadori, Richard F. Schlenk, Uwe Platzbecker, Francesco Lo‐Coco

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: